Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
49.09
-1.43 (-2.83%)
At close: Aug 21, 2026, 4:00 PM EDT
49.20
+0.11 (0.22%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Structure Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 272.64 | 799.62 | 169.51 | 129.79 | 26.09 | 105.31 |
Short-Term Investments | 1,070 | 646.57 | 714.01 | 337.53 | 64.75 | 2 |
Cash & Short-Term Investments | 1,343 | 1,446 | 883.52 | 467.32 | 90.84 | 107.31 |
Cash Growth | 70.71% | 63.69% | 89.06% | 414.44% | -15.35% | 186.57% |
Other Receivables | - | 100 | - | - | - | - |
Receivables | - | 100 | - | - | - | - |
Prepaid Expenses | 29.37 | 24.11 | 7.69 | 6.29 | 2.25 | 1.94 |
Total Current Assets | 1,372 | 1,570 | 891.21 | 473.61 | 93.09 | 109.25 |
Property, Plant & Equipment | 12.39 | 12.9 | 7.01 | 8.36 | 1.29 | 1.79 |
Long-Term Deferred Charges | - | - | - | - | 3.4 | 0.1 |
Other Long-Term Assets | 41 | 0.72 | 5.11 | 0.05 | 0.06 | 0.01 |
Total Assets | 1,425 | 1,584 | 903.33 | 482.02 | 97.85 | 111.16 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.13 | 13.86 | 8.02 | 4.74 | 6.01 | 3.48 |
Accrued Expenses | 52.39 | 46.54 | 26.3 | 18.56 | 6.57 | 4.59 |
Current Portion of Leases | 2.6 | 2.88 | 1.7 | 1.44 | 0.26 | 0.35 |
Current Income Taxes Payable | - | - | - | - | 0.17 | 0.23 |
Total Current Liabilities | 66.11 | 63.29 | 36.02 | 24.74 | 13.01 | 8.66 |
Long-Term Leases | 3.63 | 3.61 | 2.16 | 4.01 | - | 0.27 |
Other Long-Term Liabilities | 1.27 | 0.65 | 0.3 | 0.3 | - | - |
Total Liabilities | 71.01 | 67.54 | 38.49 | 29.05 | 13.01 | 8.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 2,010 | 1,986 | 1,193 | 659 | 1.92 | - |
Retained Earnings | -652.43 | -470.3 | -329.1 | -206.57 | -116.95 | -64.74 |
Comprehensive Income & Other | -3.45 | 1.05 | 0.91 | 0.52 | -0.11 | - |
Total Common Equity | 1,354 | 1,516 | 864.84 | 452.97 | -115.14 | -64.74 |
Shareholders' Equity | 1,354 | 1,516 | 864.84 | 452.97 | 84.84 | 102.23 |
Total Liabilities & Equity | 1,425 | 1,584 | 903.33 | 482.02 | 97.85 | 111.16 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.23 | 6.49 | 3.86 | 5.45 | 0.26 | 0.62 |
Net Cash (Debt) | 1,336 | 1,440 | 879.66 | 461.87 | 90.58 | 106.69 |
Net Cash Growth | 71.60% | 63.67% | 90.45% | 409.90% | -15.10% | 187.06% |
Net Cash Per Share | 20.02 | 24.32 | 16.71 | 12.57 | 28.35 | 39.31 |
Filing Date Shares Outstanding | 71.31 | 70.84 | 57.34 | 46.6 | 38.24 | 3.63 |
Total Common Shares Outstanding | 71.22 | 70.84 | 57.29 | 46.41 | 3.51 | 3.63 |
Working Capital | 1,306 | 1,507 | 855.19 | 448.87 | 80.08 | 100.59 |
Book Value Per Share | 19.02 | 21.41 | 15.10 | 9.76 | -32.81 | -17.83 |
Tangible Book Value | 1,354 | 1,516 | 864.84 | 452.97 | -115.14 | -64.74 |
Tangible Book Value Per Share | 19.02 | 21.41 | 15.10 | 9.76 | -32.81 | -17.83 |
Machinery | - | 6.81 | 3.75 | 2.51 | 1.27 | 1.15 |
Construction In Progress | - | 1.28 | - | - | - | - |
Leasehold Improvements | - | 1.54 | 1.36 | 1.36 | 0.11 | 0.11 |